Search hospitals
>
Missouri
>
Saint Louis
Washington University School Of Medicine
Claim this profile
Saint Louis, Missouri 63110
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
Conducts research for Solid Tumors
3130 reported clinical trials
429 medical researchers
Summary
Washington University School Of Medicine is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer, Solid Tumors and other specialties. Washington University School Of Medicine is involved with conducting 3,130 clinical trials across 2,259 conditions. There are 429 research doctors associated with this hospital, such as Robert J. Hayashi, Brian A Van Tine, M.D., Ph.D., Timothy R Smith, and Douglas R. Adkins.
Area of expertise
Cancer
Washington University School Of Medicine has run 320 trials for Cancer. Some of their research focus areas include:
Lung Cancer
Washington University School Of Medicine has run 229 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Robert J. Hayashi
Washington University School of Medicine
8 years of reported clinical research
Brian A Van Tine, M.D., Ph.D.
Washington University School of Medicine
4 years of reported clinical research
Timothy R Smith
StudyMetrix Research
6 years of reported clinical research
Douglas R. Adkins
Washington University School of Medicine
7 years of reported clinical research
Clinical Trials running at Washington University School Of Medicine
Lung Cancer
Breast Cancer
Ovarian Cancer
Breast cancer
Colorectal Cancer
Brain Tumor
Testicular cancer
Multiple Myeloma
Cancer
Prostate Cancer
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting
2 awards
Phase 3
14 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Washington University School Of Medicine?
Washington University School Of Medicine is a medical facility located in Saint Louis, Missouri. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer, Solid Tumors and other specialties. Washington University School Of Medicine is involved with conducting 3,130 clinical trials across 2,259 conditions. There are 429 research doctors associated with this hospital, such as Robert J. Hayashi, Brian A Van Tine, M.D., Ph.D., Timothy R Smith, and Douglas R. Adkins.
Where is Washington University School Of Medicine located?
**Washington University School of Medicine Hospital** - **Location:** Situated in St. Louis, Missouri, on the Washington University Medical Campus, adjacent to Forest Park and the Central West End and Grove neighborhoods. The main entrance is located at 216 S. Kingshighway Blvd, St. Louis, MO, US. - **Contact Information:** For assistance, please call 314.362.5194 or toll-free at 800.451.4892. Our staff is available to meet you at the door, guide you to your appointment, and assist with any other guest services required.
Who should I call to ask about financial aid or insurance network?
**Washington University School of Medicine Financial Assistance and Insurance Inquiries:** - Contact the Office of Student Financial Planning for financial assistance and insurance-related inquiries at 314-362-6845 or toll-free at 888-840-3239. Email: MedFinancialAid@wustl.edu. Address: Campus Box 8059, 660 S. Euclid Ave., St. Louis, MO 63110-1093. **Washington University Physicians Patient Billing and Insurance Issues:** - For patient billing and insurance-related issues, contact the Patient Services line at 314-273-0500 (option 4) or toll-free at 800-862-9980. Assistance is available 24/7 for automated inquiries and during business hours for live support. **UW Medicine Financial Assistance for Patients:** - Patients in need of financial assistance for medically necessary care can access the Financial Assistance Application Form.
What insurance does Washington University School Of Medicine accept?
The Washington University School of Medicine accepts a wide range of insurance plans, including Medicare, commercial health insurance plans, Health Exchange Market plans, and Medicaid Government and Private Providers. They are part of Medicare Government and Private Providers, offering Traditional Medicare Part B and various private Medicare Advantage plans such as Anthem BCBS MediBlue Plus HMO, Cigna Preferred Medicare HMO, and more. For commercial health insurance, they accept plans from providers like Aetna, Anthem BCBS, Cigna, and United HealthCare. It's advised for patients to verify their current coverage with their plan administrator due to possible changes.
What awards or recognition has Washington University School Of Medicine received?
Washington University School of Medicine in St. Louis is renowned for its research excellence, securing over $824.6 million in grants and contracts in the 2023 fiscal year. It boasts 16 fellows of the National Academy of Sciences and 28 members of the National Academy of Medicine. The school is also committed to diversity, equity, and inclusion, with various initiatives to enhance representation in medical research and healthcare professions.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.